Geriatric Pharmacology

Reduced renal or hepatic function can change how quickly a medication is eliminated or metabolized, allowing drug exposure to rise at a given dose. Age-related changes in body composition can also alter distribution. Consequently, prescribing may require individualized dose selection rather than relying on a standard regimen, with safety evaluated alongside the intended therapeutic benefit.

Changes in receptor sensitivity can modify pharmacodynamic responses, meaning the body may react differently even when medication concentrations are similar. An older adult may therefore experience stronger or weaker therapeutic effects or adverse effects than expected. Recognizing this variation helps clinicians interpret responses carefully and select treatment intensity according to the individual’s risks and goals.

Multiple illnesses can change treatment priorities and make medication effects more difficult to interpret, while concurrent medications increase the possibility of interactions. These combined factors can amplify adverse effects or reduce therapeutic safety. Reviewing the complete treatment situation is therefore essential when selecting medicines, especially when potential harms include falls, cognitive effects, or toxicity.

Evaluation should consider absorption, distribution, metabolism, and elimination, because aging can affect each part of a medication’s pharmacokinetic profile. Renal and hepatic function, body composition, and receptor sensitivity provide important context for interpreting drug exposure and response. Considering these variables together supports more appropriate dose requirements and reduces reliance on assumptions based only on chronological age.

Medication reconciliation helps clinicians examine a person’s medication regimen as a whole rather than considering each prescription in isolation. This is particularly important when several illnesses and medications are present, because interactions and cumulative adverse effects may otherwise be missed. The review supports safer treatment selection and can identify situations requiring closer monitoring or reconsideration.

Monitoring should connect the intended therapeutic benefit with possible harms, including falls, cognitive effects, and toxicity. Clinicians can use the individual’s response and relevant age-related changes in renal or hepatic function to reassess whether treatment remains appropriate. This ongoing evaluation supports individualized prescribing and helps identify when dose requirements or the treatment plan should change.

Deprescribing may be considered when the expected benefit of a medication no longer justifies its risks or treatment burden. The decision requires reviewing the person’s illnesses, concurrent medications, medication response, and potential harms such as falls, cognitive effects, or toxicity. Within individualized care, this process helps balance therapeutic goals with medication safety.